enVVeno Medical Corporation (NVNO) Financials
NVNO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 22.7 million | 2.0 million |
| March 31, 2026 | 26.1 million | 2.4 million |
| Dec. 31, 2025 | 29.6 million | 2.4 million |
| Sept. 30, 2025 | 32.4 million | 2.9 million |
NVNO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.5 million | 397000 |
| March 31, 2026 | -3.2 million | 467000 |
| Dec. 31, 2025 | -3.4 million | 637000 |
| Sept. 30, 2025 | -4.4 million | 688000 |
NVNO Net Income
No data available :(
NVNO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 21.5 million | - | 505000 |
| March 31, 2026 | 24.9 million | - | 207000 |
| Dec. 31, 2025 | 28.2 million | - | 700000 |
| Sept. 30, 2025 | 31.0 million | - | 791000 |
NVNO Shares Outstanding
NVNO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 2.1 million | 1.7 million | - |
| March 31, 2026 | - | 2.1 million | 2.0 million | - |
| Dec. 31, 2025 | - | 1.9 million | 1.9 million | - |
| Sept. 30, 2025 | 5000 | 2.6 million | 2.2 million | - |
NVNO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 124000 |
| Dec. 31, 2025 | - | 117000 |
| Sept. 30, 2025 | - | 120000 |
NVNO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NVNO
Price: $11.04
52 week price:
Earnings Per Share: -24.97 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 50300
Market Capitalization: 7.4 million